PeptiFinder Biotech is the pioneering CRO specializing in mRNA display technology. They leverage a superior mRNA display platform featuring a variety of libraries (linear, monocyclic, and bicyclic peptides) with ultra-high diversity (up to 10^15), which can be screened against nearly any biological target of interest rapidly (6-8 weeks) with a remarkable success rate of over 95%.
By incorporating unnatural amino acids into peptide libraries, PeptiFinder mRNA display platform can generate peptides with enhanced physiochemical properties and optimized pharmacokinetics. They also offer custom library designs tailored to specific client needs. In addition, they provide downstream services including ELISA/SPR hit confirmation, macrocyclic peptide DEL screening, peptide synthesis, and hit optimization.
quick proposal
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.
